- Home
- ROIV vs FNF Comparison
ROIV vs FNF Comparison
Compare ROIV & FNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | FNF |
|---|---|---|
| Founded | 2014 | 1847 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | FNF |
|---|---|---|
| Price | $21.33 | $55.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $24.31 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 8.3M | 1.3M |
| Earning Date | 02-09-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 3.83% |
| EPS Growth | N/A | ★ 55.69 |
| EPS | N/A | ★ 4.29 |
| Revenue | $20,329,000.00 | ★ $14,060,000,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | $741.42 | $9.59 |
| P/E Ratio | ★ N/A | $12.65 |
| Revenue Growth | N/A | ★ 3.92 |
| 52 Week Low | $8.73 | $50.61 |
| 52 Week High | $23.47 | $66.72 |
Technical Indicators
Market Signals| Indicator | ROIV | FNF |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 47.57 |
| Support Level | $21.36 | $54.59 |
| Resistance Level | $22.21 | $55.32 |
| Average True Range (ATR) | 0.73 | 0.98 |
| MACD | -0.17 | -0.08 |
| Stochastic Oscillator | 19.30 | 40.91 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.